Top Buy
| Security | Buy | Sell | Buy (1W) ▼ | Sell (1W) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Viking Therapeutics Inc | 6 | 0 | 1 | 0 | €73.62 | €100.00 | 35.833% |
| Anika Therapeutics | 5 | 0 | 1 | 0 | €26.40 | €28.29 | 7.162% |
| AnaptysBio Inc | 9 | 1 | 1 | 0 | €23.80 | €46.24 | 94.286% |
| Rigel Pharmaceutical Inc. | 10 | 0 | 1 | 0 | €0.94 | €13.77 | 1362.102% |
| US Physical Therapy Inc. | 8 | 1 | 1 | 0 | €97.50 | €109.94 | 12.763% |
| MannKind Corp. | 8 | 0 | 1 | 0 | €4.03 | €6.03 | 49.492% |
| G1 Therapeutics | 15 | 1 | 0 | 0 | €4.77 | €10.56 | 121.177% |
| Deciphera Pharmaceuticals | 6 | 0 | 0 | 0 | €23.20 | €21.66 | -6.642% |
| Chimerix Inc. | 4 | 1 | 0 | 0 | €0.89 | €5.51 | 516.846% |
| Boston Scientific | 46 | 0 | 0 | 0 | €69.00 | €73.05 | 5.865% |
| Centene Corp. | 15 | 0 | 0 | 0 | €71.44 | €82.57 | 15.580% |
| Icu Medical Inc. | 3 | 0 | 0 | 0 | €92.00 | €124.85 | 35.704% |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 0 | 0 | €39.40 | €50.00 | 26.904% |
| Quest Diagnostics Inc. | 4 | 0 | 0 | 0 | €128.20 | €144.44 | 12.671% |
| Iovance Biotherapeutics Inc. | 19 | 3 | 0 | 0 | €12.38 | €25.20 | 103.577% |
| Brainstorm Cell | 1 | 0 | 0 | 0 | €0.35 | - | - |
| Cellectar BioSciences Inc. | 7 | 8 | 0 | 0 | €3.00 | €10.55 | 251.527% |
| Regeneron Pharmaceuticals Inc. | 34 | 1 | 0 | 0 | €899.00 | €957.22 | 6.476% |
| Viracta Therapeutics Inc. | 2 | 0 | 0 | 0 | €0.75 | - | - |
| Thermo Fisher Scientific Inc. | 26 | 0 | 0 | 0 | €535.10 | €566.65 | 5.895% |
| Kala Pharmaceuticals Inc. | 4 | 0 | 0 | 0 | €6.23 | €19.86 | 218.859% |
| ImmunityBio Inc. | 3 | 0 | 0 | 0 | €7.46 | €10.00 | 34.120% |
| Vanda Pharmaceuticals | 4 | 0 | 0 | 0 | €4.70 | €5.00 | 6.383% |
| Humana Inc. | 23 | 0 | 0 | 0 | €308.70 | €439.88 | 42.493% |
| Vericel Corp. | 1 | 0 | 0 | 0 | €43.80 | - | - |